These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33672310)

  • 1. Stability Evaluation of Extemporaneously Compounded Vancomycin Ophthalmic Drops: Effect of Solvents and Storage Conditions.
    Ross C; Syed B; Pak J; Jhanji V; Yamaki J; Sharma A
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33672310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability-indicating HPLC method to determine the stability of extemporaneously prepared vancomycin oral solution cups.
    Rochani A; Nguyen V; Becker R; Kaushal G
    Am J Health Syst Pharm; 2022 Jan; 79(1):e34-e40. PubMed ID: 34226929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days.
    Roura-Turet J; Rodriguez-Reyes M; Guerrero-Molina L; Soy-Muner D; López-Cabezas C
    Am J Health Syst Pharm; 2021 Jul; 78(15):1444-1447. PubMed ID: 33950182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of insulin eye drops in the treatment of refractory corneal ulcers.
    Cuartero-Martínez A; Hermelo-Vidal G; Castro-Balado A; Gómez-García Á; González-Barcia M; Otero-Espinar FJ; Fernández-Ferreiro A; Mondelo-García C
    Farm Hosp; 2022 Nov; 46(6):335-339. PubMed ID: 36520572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of deep freezing on the stability of 25 mg/ml vancomycin ophthalmic solutions.
    Sautou-Miranda V; Libert F; Grand-Boyer A; Gellis C; Chopineau J
    Int J Pharm; 2002 Mar; 234(1-2):205-12. PubMed ID: 11839451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding.
    Chen P; Mar Z; Giannetti A; Hughes S; Gilbert J; Zhao F
    Hosp Pharm; 2022 Feb; 57(1):69-75. PubMed ID: 35521008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmaceutical investigation of vancomycin hydrochloride eye drops and their topical application to MRSA eye infection].
    Itoh M; Aoyama T; Iemoto A; Nakajima K; Amano S; Nakamura H; Sato H; Iga T
    Yakugaku Zasshi; 2001 Jun; 121(6):433-9. PubMed ID: 11433777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Storage of extemporaneously prepared ophthalmic antimicrobial solutions.
    Charlton JF; Dalla KP; Kniska A
    Am J Health Syst Pharm; 1998 Mar; 55(5):463-6. PubMed ID: 9522930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of extemporaneously prepared ophthalmic solutions for mydriasis.
    Camp NA; Nadra JT; Hughes SE; Gilbert JM; Zhao F
    Am J Health Syst Pharm; 2018 May; 75(9):e231-e235. PubMed ID: 29691266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
    Karampatakis V; Papanikolaou T; Giannousis M; Goulas A; Mandraveli K; Kilmpasani M; Alexiou-Daniel S; Mirtsou-Fidani V
    Acta Ophthalmol; 2009 Aug; 87(5):555-8. PubMed ID: 18700884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV; Wei B; Liang D
    Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability studies of five anti-infectious eye drops under exhaustive storage conditions.
    Curti C; Lamy E; Primas N; Fersing C; Jean C; Bertault-Peres P; Vanelle P
    Pharmazie; 2017 Dec; 72(12):741-746. PubMed ID: 29441959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of vancomycin in an extemporaneously compounded ophthalmic solution.
    Fuhrman LC; Stroman RT
    Am J Health Syst Pharm; 1998 Jul; 55(13):1386-8. PubMed ID: 9659967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
    Kodym A; Wiśniewski A; Knioła D; Olejniczak M
    Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of cefazolin sodium eye drops.
    How TH; Loo WY; Yow KL; Lim LY; Chan EW; Ho PC; Chan SY
    J Clin Pharm Ther; 1998 Feb; 23(1):41-7. PubMed ID: 9756111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and stability of an extemporaneously compounded oral solution of chlorpromazine HCl.
    Prohotsky DL; Juba KM; Zhao F
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):367-70. PubMed ID: 25338106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of amphotericin B in 5% dextrose ophthalmic solution.
    Peyron F; Elias R; Ibrahim E; Amarit-Combralier V; Bues-Charbit M; Balansard G
    Int J Pharm Compd; 1999; 3(4):316-20. PubMed ID: 23985715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability-indicating HPLC method for the determination of the stability of oxytocin parenteral solutions prepared in polyolefin bags.
    Kaushal G; Sayre BE; Prettyman T
    Drug Discov Ther; 2012 Feb; 6(1):49-54. PubMed ID: 22460429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of 5-Fluorouracil in an extemporaneously compounded ophthalmic solution.
    Fuhrman LC; Godwin DA; Davis RA
    Int J Pharm Compd; 2000; 4(4):320-3. PubMed ID: 23985397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.